Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer
Authors
Keywords
-
Journal
GYNECOLOGIC ONCOLOGY
Volume 143, Issue 3, Pages 504-510
Publisher
Elsevier BV
Online
2016-09-25
DOI
10.1016/j.ygyno.2016.09.018

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.